Synergistic effect of Ir-(COT)-pentamidine alizarin red and pentamidine, amphotericin B, and paromomycin on Leishmania donovani

Acta Tropica

Volumn 70, Issue 2, 1998, Pages 239-245

  Mbongo, N ^a,b   Loiseau, P M ^b   Craciunescu, D G ^c   Robert Gero, M ^a  

^a CNRS   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

^c UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Amphotericin B; Ir (COT) pentamidine; Synergistic effect

Indexed keywords

ALIZARIN RED S; AMPHOTERICIN B; IRIDIUM COMPLEX; MEGLUMINE ANTIMONATE; ORGANOMETALLIC COMPOUND; P 2368; PAROMOMYCIN; PENTAMIDINE ISETHIONATE; UNCLASSIFIED DRUG;

AMASTIGOTE; ANIMAL EXPERIMENT; ANIMAL MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG POTENTIATION; INTRAPERITONEAL DRUG ADMINISTRATION; LEISHMANIA DONOVANI; LEISHMANIASIS; MOUSE; NONHUMAN; PROMASTIGOTE; SHORT SURVEY;

ANIMALIA; LEISHMANIA DONOVANI;

EID: 17144465468     PISSN: 0001706X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0001-706X(98)00018-7     Document Type: Article

References (13)

1. Croft, S.L., 1988. Recent developments in the chemotherapy of leishmaniasis. Trends Pharmacol. Sci. 9, 376-381.
2. Croft, S.L., Neal, R.A., Craciunescu, D.G., Certad-Fombona, G., 1992. The activity of platinum, iridium and rhodium drug complexes against Leishmania donovani. Trop. Med. Parasitol. 43, 24-28.
3. Dreyfuss, G., Penicaut, B., Nicolas, J.A., Craciunescu, D.G., Loiseau, P.M., 1993. Trypanocidal activity and platinum plasma kinetics of cis-Pt pentamidine iodide in Trypanosoma brucei sheep model. Trop. Med. Parasitol. 44, 95-98.
4. Farrell, N.P., Williamson, J., McLaren, D.J.M., 1984. Trypanocidal and antitumor activity of platinum metal and platinum-metal-drug dual function complexes. Biochem. Pharmacol. 33, 961-971.
5. Gayral, P., Loiseau P.M., Craciunescu, D.G., 1992. Complexes organometalliques d'iridium ayant une action antiparasitaire, French Patent no. 9200669.
6. Herwaldt, B., Berman, J.D., 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies. Am. J. Trop. Med. Hyg. 46, 296-306.
7. Loiseau, P.M., Craciunescu, D.G., Doadrio-Villarejo, J.C., Certad-Fombona, G., Gayral, P., 1992. Pharmacomodulations on new organometallic complexes of Ir, Pt, Rh, Pd, Os: in vitro and in vivo trypanocidal study against Trypanosoma brucei brucei. Trop. Med. Parasitol. 43, 110-114.
8. Mbongo, N., Loiseau, P.M., Lawrence, F., Bories, C., Craciunescu, D.G., Robert-Gero, M., 1997. In vitro sensitivity of Leishmania donovani to organometallic derivatives of pentamidine. Parasitol. Res. 83, 515-517.
9. Mbongo, N., Loiseau, P.M., Lawerence, F., Craciunescu, D.G., Robert-gero, M., 1998. Uptake and antileishmanial action of an organometallic complex related to pentamidine into Leishmania donovani promastigotes. Arzneim Fouch. Drug Res., in press.
10. Mossman, T., 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-63.
11. Neal, R.A., Croft, S.L., 1984. An in vitro system for determining the activity of compounds against the intracellular amastigote form of Leishmania donovani. J. Antimicrob. Chemother. 14, 463-475.
12. Olliaro, P.L., Bryceson, A.D.M., 1993. Practical progress and new drugs for changing patterns of leishmaniasis. Parasitol. Today 9, 323-328.
13. Sands, M., Kron, M., Brown, R.B., 1985. Pentamidine: a review. Rev. Infect. Dis. 7, 625-634.